UK's NICE Recommends Genetic Testing for Therapy Selection in Stroke Patients
Clopidogrel is less effective at preventing subsequent strokes in patients with certain variations in the CYP2C19 gene and testing could aid treatment selection.
NICE Recommends Genedrive Test in Draft Guidance to Prevent Hearing Loss in Newborns
NICE recommended that Genedrive's MT-RNR1 ID Kit should be adopted by the NHS for the prevention of antibiotic-induced hearing loss.
Top Five Articles on 360Dx Last Week: Roche FDA OK for COVID-19 Test; Bio-Rad Q3 Earnings; More
Last week, 360Dx's readers were most interested in Roche obtaining US Food and Drug Administration 510(k) clearance for its COVID-19 PCR test.
The institute recently decided to create a new way to evaluate new tests, called the Early Value Assessment program, which has a six-month turnaround time.
UK's NICE to Accelerate Assessment of Genedrive Test
NICE plans to assess Genedrive's MT-RNR1 test for antibiotics-induced hearing loss in infants via a new program.